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The activation, growth, and differentiation of B cells are modulated, in part,
by T cell-derived lymphokines. One such lymphokine, B cell-stimulatory factor
1' (BSF-1) acts during several different phases of B cell activation and differen-
tiation. Howard etal. (1)initiallydescribed BSF-1 asalymphokine that synergized
with anti-Ig in a B cell proliferation assay. It was later reported that BSF-1
induced small, resting B cells to proliferate in response to anti-Ig (2, 3), and
increased the expression of class II MHC molecules (Ia antigens) on resting B
cells (4, 5). BSF-1 also induces LPS-stimulated B cells to secrete IgGI (6) and
IgE (7).
Purified BSF-I can be distinguished from IL-2 by its physicochemical proper-
ties (8-10). We purified BSF-1 from the supernatant (SN) of the Con A-
stimulated alloreactive T cell line, PK 7.1 (11), by the procedures of Ohara et
al. (10), and noted that the fractions containing BSF-1 also induced the prolif-
eration of the IL-2-dependent helper type T cell line, HT-2. In this study, we
show that this proliferation is caused by BSF-1, and not by contaminating IL-2.
Furthermore, not all T cells or T cell lines are equally susceptible to the growth-
promoting activity of BSF-1, since it appears to induce growth primarily of Th
that induce activation and differentiation of B cells.
Materials and Methods
Animals.
￿
Female (C57BL/6 X DBA/2)F, (BDF,) mice, 8-10 wk ofage, were purchased
from TheJackson Laboratory, Bar Harbor, ME. All animals were maintained in laminar
flow hoods.
Cell Lines.
￿
The IL-2-dependent cell line, HT-2 (12), was the generous gift of Drs.
Kappler and Marrack (National Jewish Hospital, Denver, CO), and was maintained in a
1 :1 mixture of murine spleen cell ConA SN and RPMI-1640 medium containing 25 mM
Hepes (Gibco Laboratories, Grand Island, NY), 10% heat-inactivated FCS (Hazleton
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' Abbreviations used in this paper:
￿
BCDF, B cell differentiation factor; BSF-1, B cell-stimulatory
factor 1; BSS, balanced salt solution; DxS, dextran sulfate; GAMIg, goat anti-mouse Ig; GM-CSF,
granulocyte/macrophage colony-stimulating factor;MLC, mixedlymphocyte culture; RAMIg, rabbit
anti-mouse immunoglobulin; S, Sepharose; SN, supernatant; Ta, alloreactive T cells; Tc, cytotoxic
"I' cells; TFA, trifluoroacetic acid; TMS-CpG, trimethylsilyl-coated controlled pore glass beads.
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Dutchland, Denver, PA), penicillin (100 U/ml), streptomycin (100 ug/ml), gentamycin
(10 kg/ml), L-glutamine (2 mM), 2-ME (5 X 10-5 M), and a-methyl mannoside (60 mM).
Another IL-2-dependent T cell line, CTLL-2 (13), was obtained from the American Type
Culture Collection (Rockville, MD) and was maintained in a 1 :1 mixture of murine spleen
cell Con A SN and RPMI 1640 containing 25 mM HEPES and 5% heat-inactivated FCS,
penicillin (100 U/ml), streptomycin (100,ug/ml), gentamycin (10 Fcg/ml), L-glutamine (2
mM), sodium pyruvate (2 mM) and a-methyl-mannoside (60 mM). Six other T cell lines
were maintained as described and included the alloreactive T cell line, PK 7.1-E10 (11);
two long-term murine T cell clones of common origin, clone 96 and clone 29 (14), which
are used as indicator cells in an IL-2 assay and one of which (clone 96) has been shown to
possess cytotoxic activity against P815 mastocytoma cells (15), and the CBA anti-A.AL
cytotoxic T cell lines L.13.D.4A, L.13 .D.8, and L.13.D.17 (16). Th lines specific for
KLH, BK-2, 8-5 (17), and A-12 were maintained by a modification ofthe method described
by Kimoto and Fathman (18), by 7-d antigenic stimulation and rest cycles in cultures
containing irradiated syngeneic spleen cells and murine Con A SN.
Reagents and mAbs. Affinity-purified anti-BSF-I mAb 11B11 (19) and its isotype-
matched control, 50C1 (anti-DNP), were kindly provided by Drs. Ohara and Paul
(National Institutes of Health, Bethesda, MD). The anti-IL-2 mAb, DMS-1, which reacts
with human and murine IL-2, was purchased from Genzyme (Boston, MA). Ascites fluid
containing the anti-murine IL-2-R mAb, AMT-13, and its isotype-matched control, 23/7,
were prepared as described previously (20). The AMT-13 ascites contained 0.5 mg/ml of
antibody. rIL-2 was obtained from AmGen Biologicals (Thousand Oaks, CA).
Preparation ofIL-2 andBSF-1-containing SN.
￿
SN from PMA-stimulated EL-4 thymoma
cells was prepared as described previously (21). Such SN contained high levels of IL-2
activity and negligible levels of BSF-1 activity.
SN from Con A-pulsed PK 7.1 cells were prepared as described previously (11). Such
SNs contained greater than 103 U/ml of BSF-1 activity and were devoid of IL-2 activity.
BSF-1 Assay. BSF-I activity was measured by a modification (22, 23) of the previously
described anti-IgM costimulation assay (1). 5 X 10' small (1 .083-1 .222 g/ml), Percoll-
fractionated B cells (23) were cultured for 3 d in a volume of 200 Al containing 10 U1 of
a 10% suspension of goat anti-mouse Ig coupled to Sepharose (S-GAMIg) (22, 24) and
SN or purified lymphokines (20 ul). The cells were then pulsed with 1 UCi/well of
['H]thymidine and harvested 16 h later. 1 U of BSF-I was designated as the reciprocal of
the dilution containing 50% of the maximal activity of a standard BSF-1-containing PK
7.1 SN .
IL-2 Assay.
￿
IL-2 activity was assayed by measuring the [3H]thymidine uptake of IL-2-
dependent HT-2 (12) or CTLL-2 (13) cell lines in response to IL-2- or to BSF-1-containing
SN . One HT-2 line has been maintained in our laboratory for 3 yr and the other was
recently obtained from Dr. Robert Coffman (DNAX Research Institute of Molecular and
Cellular Biology, Palo Alto, CA). For the assay, 20-ul aliquots/well of a 2 .5 X 105 cells/ml
suspension were added to 70 j1/well of different dilutions of the BSF-1 or IL-2-containing
SN. Cells were pulsed with 1 ACi/well of [3H]thymidine after 48 h of incubation at
37°C/5% COz in air, and 16 h later the cells were harvested.
IL-2 Assay on TCell Blasts.
￿
Murine Con A T cell blasts were prepared as described by
Malek et al . (25). For the assay, the cells were cultured at a density of 2 .5 X 105 cells/ml
in 200 Al/well of assay medium containing various dilutions of the IL-2- or BSF-1-
containing SN or the purified lymphokines. After 48 h the cells were pulsed with 1
,uCi/well of [3H]thymidine, and 16 h later the cells were harvested.
B Cell Growth Factor (BCGF) II Assay.
￿
BCGF-II activity was assayed by measuring the
ability of the SN or purified lymphokines to synergize with dextran sulfate (DxS) in a B
cell proliferation assay (26). B cells were not subjected to a Percoll density gradient
fractionation before culture, since BCGF-II acts on low density B cells (23). Test SN were
added on day 0, on day 3 cells were pulsed with [3H]thymidine, and were harvested 16 h
later.
BCDFforIgGI (BCDF-'Y) Assay.
￿
BCDF-,y activity was measured as described previously
(6, 27), using B cells prepared as described for the BCGF-II assay. 20 ug/ml LPS was582
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FIGURE 1 .
￿
[sH]thymidine incorporation of HT-2 cells cultured in the presence of serial two-
fold dilutions of IL-2-containing EL-4 SN (0) and the BSF-1-containing PK 7.1 SN (O). SNs
were prepared, and [sH]thymidine incorporation assays were performed as described in
Materials and Methods.
added at the initiation of culture and BSF-1 was added a day later. On day 6, the culture
SN were assayed for IgGI by a RIA.
BCDF for IgM (BCDF-,u) Assay.
￿
SN or purified lymphokines were tested for BCDF-A
activity by their ability to stimulate the secretion of IgM from the in vitro-adapted BCL,
cell line, 3113 (28). T cell SN were added on day 0, and on day 6 the culture SNs were
assayed for IgM by a /A-specific RIA.
Gel Filtration.
￿
Gel filtration of the different SN was carried out at 4°C using a 2.5 X
50 cm Sephacryl S-200 column (Pharmacia Fine Chemicals, Uppsala, Sweden) equilibrated
with Tris-buffered saline (50 mM, pH 7.4) containing 0.1 % sodium azide. After chroma-
tography, BSA was added to the different fractions at a final concentration of 1 mg/ml,
and the fractions were dialyzed against 3 changes of PBS (3 X 1 liter) and once against
RPMI-1640 (1 X 1 liter).
Purification of IL-2 and BSF-1.
￿
The initial step in the partial purification of IL-2 or
BSF-1 was carried out as described (10, 29) by adsorption to trimethylsilyl-coated TMS-
CpG and subsequent elution by a 50% acetonitrile/0.2 M NaCl/0.1 % TFA solution. This
procedure resulted in the adsorption of >95% of the BSF-1 or IL-2 activities from the
SN with minimal contamination by BCGF-I1 and BCDF-ft activities. Reverse-phase HPLC
was carried out as described previously (10), in a model 332 gradient liquid chromatograph
(Beckman Instruments, Inc., Fullerton, CA) and an Altex Ultrasphere ODS (250 X 4.6
mm, 5 pm) reverse-phase column (Altex Scientific, Berkeley, CA).
Results
HT-2 Growth-promoting Activity ofPK 7.1 SN.
￿
The HT-2 cell line was derived
from T cellsthat provide IAd-restricted help to B cells foran anti-SRBC response.
The requirement of HT-2 cells for the growth-promoting activity of IL-2 is the
basis for the 1L-2 assay used by many laboratories (12). However, when HT-2
cells were cultured with T cell SN lacking IL-2, namely, PK 7.1 (11), the HT-2
cells proliferated, as judged by both [sH]thymidine incorporation and by an
increase in cell number. As shown in Fig. 1, the stimulation indexes obtained at
maximal stimulatory concentrations of BSF-1-containing PK 7.1 SN were about
50% as high as those obtained with maximal stimulatory concentrations of the
IL-2-containing EL-4 SN. Proliferation was observed at 24, 48, and 72 h using
the ['H]thymidine incorporation assay, and was not affected by the inclusion of
a-methyl-mannoside (20 mg/ml) in the medium (data not shown), suggesting
that the proliferative activity of SN from Con A-pulsed PK 7.1 cells is not due
to contaminating Con A.
Purification of IL-2 and BSF-1.
￿
When subjected to gel filtration on Sephacryl
S-200 columns, the HT-2 growth-promoting activity of EL-4 cell SNs eluted withFERNANDEZ-BOTRAN ET AL .
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FIGURE 2 .
￿
HPLC elution profiles of the HT-2 growth-promoting (*) andBSF-1 (0) activities
from EL-4 (A)and PK 7.1 (B) cell SNs . SNs were adsorbed with TMS-CpG (Sepralyte, 40 /.Lm)
and the IL-2 or BSF-1 activities eluted from the beads with 50% acetonitrile in 0.2 M
NaCl/0 .1%TFA . The eluates were lyophilized, reconstituted with distilled waterand applied
to a reverse-phase Altex UltrasphereODS column .
an apparent M, of 30,000, in concordance with a previous report (30). The HT-
2 growth-promoting activity of PK 7 .1 SN, however, coeluted with BSF-1 and
had an apparent M r of 18,000 . No IL-2 activity was detected in the PK 7 .1 SN
and no BSF-1 activity was detected in the EL-4 SN .z
To characterize further the HT-2 growth-promoting activity present in PK
7.1 SN, both HT-2 growth-promoting activity and BSF-1 activity were purified
from PK 7 .1 SN by TMS-CpG adsorption and reverse-phase HPLC, as described
(10) . IL-2 waspurified from EL-4 SN by the same procedure. Thebeadsabsorbed
the HT-2 growth-promoting activities from both SN and the anti-Ig-mediated
costimulator and BCDF-y activities from the PK 7 .1 SN . The 50% acetonitrile
eluates that contained all three activities were then subjected to reverse-phase
HPLC, as described in Materials and Methods. As shown in Fig. 2A, the IL-2
activity from the EL-4 SN eluted at 60-80% acetonitrile . No BSF-1 activity was
detected in the original EL-4 SNs, nor in any of the HPLC fractions . Using a
system similar to the one described here, the BSF-1 activity has been reported
to elute at acetonitrile concentrations of 47-49% (10, 31) . As shown in Fig . 2B,
both the BSF-1 and the HT-2 growth-promoting activities present in the PK 7.1
SN coeluted at 47-50% acetonitrile . No HT-2 growth-promoting activity was
detected in those fractions in which IL-2 should have eluted (60-80% acetoni-
trile) . The fractions containing the BSF-1 activity were, as expected, also positive
for BCDF-y activity, according to previous reports by our group (6) and other
(32, 33) that BSF-1 andBCDF-y are identical . No BCGF-11 or BCDF-,u activities
were detected in these fractions .
Fffect ofAnti-BSF-1 mAb, 11B11 .
￿
The above results indicated that the material
containing the HT-2 growth-promoting activity and isolated from the PK 7.1
SN was different in size and polarity from the material containing the IL-2
z Several sublines of EL-4 cells have been generated in our laboratory . After stimulation with
PMA, some lines secrete only IL.-2 and others secrete both IL-2 and BSF-1 .584 B CELL STIMULATORY FACTOR I ACTS ON HELPER T CELLS
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￿
Inhibition of HT-2 growth-promoting activity ofpurified BSF-1 but not purified
IL-2 by mAb to BSF-1 . Constant amounts of BSF-I or IL-2 were preincubated for 30 min at
room temperature with the indicated dilutions of a 1 mg/ml stock of monoclonal anti-BSF-1,
1 1B 11 (") or isotype-matched control antibodies, 50C 1 (Q) . HT-2 cells were then added and
proliferation was measured . Results represent the mean of triplicate experiments ± SEM .
[ sH]Thymidine incorporation ofcells cultured in the absence ofadded lymphokines was 2,765
± 254 cpm .
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FIGURE 4 . Inhibition of anti-Ig costimulator activity of BSF-1 by mAb to BSF-1 . The
indicated dilution of a 1 mg/ml stock of mAbs 111311 (0) or 50C1 control (O) were
preincubated at room temperature for 60 min with constant amounts ofBSF-1 . GAMIg-S and
aliquots from a small B cell suspension were added, and BSF-1 activity was assayed as described
in Materials and Methods . Results represent the mean of triplicate experiments ± SEM .
[ sH]Thymidine incorporation of cells cultured in the absence of added lymphokines was 737
± 298 cpm .
activity isolated from the EL-4 SN . The former was similar to BSF-1 based on
its physicochemical properties . We, therefore, postulated that BSF-1 had IL-2-
like growth-promoting activity on HT-2 cells . To test this hypothesis and to
disprove the possibility of contamination of BSF-1 by an IL-2 species with
physicochemical properties similar to those of BSF-1, we tested the effects of
soluble anti-BSF-1 mAbs (I IB11), previously reported to inhibit BSF-1 activity
(19), on both the BSF-1 and HT-2 growth-promoting activities of the purified
BSF-1 and IL-2 preparations from PK 7.1 and EL-4 SN, respectively . As shown
in Fig . 3A, the HT-2 growth-promoting activity purified from PK 7.1 SN was
readily inhibitable by I IBI 1 antibody, but not by an isotype-matched anti-DNP
antibody (50C1) . In contrast, the HT-2 growth-promoting activity of the EL-4-
derived IL-2 was not affected by I IB11 (or the control antibody) at any of the
antibody concentrations tested (Fig . 3B) .
The mAb 1 1B 1 1 completely blocked the anti-Ig-mediated costimulator activity
of the PK 7 .1-derived BSF-1 at the same concentrations that inhibited the BSF-
1-mediated proliferation of HT-2 cells (Fig . 4) . A similar experiment could not
be performed with EL-4-derived IL-2 since it did not show any anti-Ig-mediated
costimulatory activity on B cells .20
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￿
Inhibition of IL-2 but not BSF-1-mediated proliferation of HT-2 cells by mAb to
IL-2 . Several dilutions of monoclonal anti-IL-2, DMS-1 (0), or normal mouse IgG control (O)
were preincubated with constant amounts of purified BSF-1 or IL-2 for 60 min at 37°C .
Aliquots of a HT-2 cell suspension were added and proliferation measured as described in
Materials and Methods . Results represent the mean of triplicate experiments ± SEM.
[sH]Thymidine incorporation of cells cultured in the absence of added lymphokines was 2,452
± 281 cpm .
Anti-IL-2 mAb Does Not Block the HT-2 Growth-promoting Activity ofBSF-1 .
￿
To
obtain additional evidence that the HT-2 growth-promoting activity of puri-
fied BSF-1 was not due to contaminating IL-2, and to investigate whether the
BSF-1-mediated proliferation ofHT-2 cells was due to autocrine production and
utilization of IL-2 in response to BSF-1, soluble anti-IL-2 mAb (DMS-1) was
added to cultures of HT-2 cells containing purified BSF-1 or rIL-2 . The anti-
IL-2 mAb failed to inhibit the proliferation caused by BSF-1, whereas the same
concentrations of antibody inhibited the rIL-2-mediated proliferation of HT-2
cells by 50-60% (Fig . 5) . These results suggest that BSF-1 purified from PK 7 .1
SN has both growth-promoting activity on HT-2 cells and anti-Ig-mediated
costimulatory activity on resting B cells, and that neither activity canbe accounted
for by contaminating or autocrine IL-2 .
Anti-IL-2-R mAb Blocks the Growth-promoting Activity of IL-2 but not BSF-1 on
HT-2 Cells . Although the above results indicate that the HT-2 growth-promot-
ing activity of BSF-1 was not due to IL-2 contamination or mediated by autocrine
IL-2 production, the proliferative signal given by BSF-1 might have resulted
from interaction with IL-2-R . To test this possibility, the anti-IL-2-R antibody,
AMT-13, previously shown to inhibit IL-2 binding and IL-2-mediated prolifer-
ation in activated murine T cells (20), was added to cultures of HT-2 cells
stimulated with rIL-2 or BSF-1 . AMT-13 antibodies blocked (by ^-70%) the
proliferation caused by HL-2 but did not affect the proliferation mediated by
BSF-1 (Fig . 6) . These result suggest that BSF-1 and IL-2 do not bind to the same
receptor, or at least the same epitope on the IL-2-R on HT-2 cells, even though
both induce their growth . The nature of the BSF-1 receptor on HT-2 cells is not
known .
Morphology ofHT-2 Cells Cultured with BSF-1 or rIL-2 .
￿
When HT-2 cells were
cultured with purified BSF-1, they showed striking changes in morphology (Fig .
7A) when compared with HT-2 cells cultured with IL-2 (Fig . 7B) . While the
cells cultured with IL-2 usually maintained a rounded shape, grew in suspension,
and formed small clusters, the cells cultured in BSF-1 acquired a flattened
appearance, produced numerous dendritic-like cytoplasmic projections, and at-
tached to the surface of the culture flask . The percentage of cells undergoing586
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FIGURE 6 .
￿
Inhibition of 1L-2 but not BSF-1-mediated proliferation of HT-2 cells by mAb to
the murine IL-2-R (AMT-13) . The indicated amounts of ascites fluid containing the mAbs
AMT-13 (0) or 23/7 control (O) were preincubated for 60 min at 37 °C with equal volumes
of a 2 .5 X 10 5 cells/ml suspension of HT-2 cells . The mixtures were then added to constant
amounts of BSF-1 or IL-2 and proliferation was measured as described in Materials and
Methods . Results represent the mean of triplicate experiments ± SEM. [sH]Thymidine
incorporation of cells cultured in the absence of addedlymphokines was 6,952 ± 1,968 cpm .
Such morphological changes in the BSF-1-containing cultures was dependent
upon the concentration and time of exposure to BSF-1 . Morphologic alterations
were evident as early as 12 h after exposure, although they did not reach a
maximum until 48 h. Compared with the proliferative activity of BSF-1, higher
concentrations of BSF-1 were required to induce morphologic changes in the
HT-2 cells, since lower concentrations of BSF-1 that promoted proliferation
failed to induce significant morphological alterations .
BSF-1 has Growth-promoting Activity on Other Subsets of T Cells.
￿
The growth-
promoting activity of BSF-I on HT-2 cells prompted us to investigate its effects
on a variety ofT cell lines and blasts . The population ofT cells to be tested was
incubated with the purified BSF-1 or IL-2 preparations for 24-48 h, and then
was assayed for [3H]thymidine incorporation . T cell lines included: (a) a second
HT-2 line obtained from DNAX ; (b) the cytotoxic, IL-2-dependent T cell line,
CTLL-2 ; (c) the long-term alloreactiveT cell clone, PK 7.1-E10 (11) ; (d) a long-
term murine T cell line (with cytotoxic activity to P815 mastocytoma cells [14,
15]), clone 96, and another long-term T cell line of similar origin, clone 29 (14) ;
(e) three CTL lines (16) ; (f) three KLH-specific Th lines (reference 17 and
unpublished observations) . The antigen-specific Th all induced IgM secretion in
B cells when cultured with TNP-KLH (data not shown) ; and (g) Con A-activated
spleen and peripheral T cell blasts (Fig . 8) . As shown in Fig . 8, the IL-2
preparation supported the growth of all the T cell lines tested . In contrast, the
BSF-1 preparation supported the growth of the Th populations (C-E) and both
HT-2 cell lines (A-B), but induced only a modest proliferation of Con AT cell
blasts (M), and no significant proliferation of the otherT cell lines, including
cytotoxic, alloreactive, and long-term T cell lines (Fig . 8 F-L) . These results
suggest that BSF-1 may act as a growth factor for only some T cell subsets. Based
on theT cells tested to date, it appears that BSF-1 acts primarily on T cells that
provide help to B cells . It will be necessary to test the effect of BSF-1 on
additional T cell lines and clones to determine if additional subsets of cells are
responsive .FERNANDEZ-BOTRAN ET AL .
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FIGURE 7 .
￿
Morphology of HT-2 cells grown in the presence of BSF-1 (A) or IL-2 (B) . HT-2
cells were grown in 25-cm2 tissue culture flasks in RPMI-1640 10% FBSmedium with purified
BSF-I or IL-2 . Microphotographs were taken after 48 h of culture using an inverted phase
contrast microscope .
Discussion
The major finding to emerge from these studies is that BSF-I, in addition to
its known effects on B cells, also induces the proliferation of some subsets ofT
cells such as HT-2 cells and antigen-specific Th (that provide help to B cells) .
Since IL-2 plays a central role in the proliferation of T cells (reviewed in588
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￿
Thymidine incorporation of different T cell lines and blasts in response to IL-2
(0) or BSF-1 (O). (A) HT-2 (maintained in our laboratory); (B) HT-2 (provided by Dr. R.
Coffman, DNAX);(C) KLH-specific Th,8-5; (D)KLH-specific Th line,A-12;(E) KLH-specific
Th line BK-2; (F) the alloreactive T cell line, PK 7.1-E10; (C) the long-term murine T cell
clonewith cytotoxicactivity to P815 mastocytoma cells, clone 96; and (H) its related clone 29;
and the cytotoxic T cell lines: (I) CTLL-2; (.J) L.13.D.4A; (K) L.I3.D.8; (L) L.73.D.17; and
(M) Con A-stimulated peripheral T cell blasts.
references 34 and 35), it was essential to show that the growth-promoting activity
of BSF-I was not due to the presence of contaminating IL-2. To this end, it was
shown that (a) PK 7.1 SNs, which lack IL-2 activity, support the proliferation of
HT-2 cells ^-50% as well as IL-2-containing EL-4 SNs; (b) The HT-2 growth-
promoting activity present in PK 7.1 SNs copurifies with BSF-1 by both gel
filtration andreverse-phase HPLC; (c) The proliferation of HT-2 cells in response
to purified BSF-1, but not to IL-2, is inhibited by anti-BSF-1 mAbs. The same
antibodies block the anti-Ig-mediated costimulatory activity of BSF-1 ; (d) anti-
IL-2 mAbs block the HT-2 growth-promoting activity of IL-2 but not BSF-1; (e)
anti-IL-2R mAbs block the HT-2 growth-promoting activity of IL-2 but not BSF-
1; and (f) BSF-1 preparations that support the growth of HT-2 cells do not
induce significant proliferation of other IL-2-dependent T cell lines, with the
exception of antigen-specific Th lines. In contrast, IL-2 supports the growth of
all the T cell lines and normal T cell blasts tested.
We have chosen the PK 7.1 SN as a source of BSF-1 because of its paucity of
IL-2 activity and its high levels of BSF-1 activity (11). Other T cell lines or clones
that fail to secrete IL-2 but secrete BSF-1 and/or other lymphokines that act on
B cells have been described (36-39). In the last year, there have been several
reports describing the partial purification of BSF-1 (10, 31, 32), and the cloning
and expression of the BSF-I cDNA (33). In these reports, no T cell growth-
promotingactivity associated with BSF-1 wasdescribed. One possible explanation
is that two groups (31, 32) used cytotoxic, IL-2-dependent T cell lines (CSP 2.1
and CTLL-2, respectively) as indicator cells in their IL-2 assays. All cytotoxic or
alloreactive T cell lines tested to date in our system have also failed to proliferate
significantly in response to BSF-1. Paradoxically, however, Ohara et al . (10) used
HT-2 cells in their IL-2 assay and could not detect any HT-2 growth-promoting
activity associated with their purified BSF-1 . This observation could be explained
by the fact that they used cloned IL-2-dependent T cells from the HT-2 line.
During the cloning process, the cells might have lost responsiveness to BSF-1,
while retaining responsiveness to IL-2. Another possible explanation is that the
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HT-2 growth-promoting activity associated with PK 7.1-derived BSF-1 is related
to its cell source. However, this possibility appears unlikely since we have recently
purified BSF-I from BSF-I-containing SN of EL-4 cells, andfoundthat it behaves
identically to that isolated from PK 7.1 SNs (unpublished observations).
If BSF-I acts primarily on Th (L3T4+, Lyt-2-), then the observation that BSF-
1 induced only modest proliferation of Con A-activated T cells could be
explained by the fact that Con A induces the preferential proliferation of Lyt-2+
cells (40). In support of this possibility is the finding that immunofluorescence
staining of Con A-activated lymph node blasts revealed that <10% of the cells
were L3T4+ (data not shown) .
Presumably, the biological effects of BSF-1 on T cells are mediated by its
binding to specific receptors on the surface of activated T cells analogous to
other hormones (35). However, BSF-I receptors have not yetbeen characterized.
Recent results from our laboratory (41) have shown that antibodies directed
against the a chain of LFA-I mimic the biological effects of BSF-I on B cells.
However, it is not yet known whether LFA-I is the receptor for BSF-I, or
another molecule that can signal resting B cells in a similar manner. It is of
interest that immunofluorescence staining of HT-2 cells with anti-LFA-1 anti-
bodies has revealed that >99% of the cells express LFA-I.
BSF-I, in contrast to IL-2, induced striking morphologic alterations of HT-2
cells, namely, increased adherence to plastic and the appearance of elongated
cytoplasmic projections. These phenotypic changes may depend on cytoskeletal
alterations . Such alterations may play a role in facilitating T-B cell interaction
and the delivery of T cell help to B cells.
The capacity of BSF-1 to induce proliferation of Th, but not of the cyto-
toxic/alloreactive type (Tc/Ta), is provocative. However, it should be emphasized
that the negative results using clones of Tc and Ta could be due to their
production and use of BSF-1, thereby abrogating their requirement for exoge-
neous BSF-1. A possible physiological role for BSF-1 is that it acts on both Th
and B cells during Th-B cell interaction . Noelle et al. (4) and Roehm et al. (5)
have reported that BSF-I increases the levels of class II MHC molecules (Ia
antigens) on the surface of resting B cells. This increase in expression of Ia
antigens may enhance the recognition of processed antigen and la by the Th (2).
A proliferative signal mediated by BSF-1 to specific Th could enhance prolifer-
ation of the specific Th in the T-B cluster. Such Th cells might subsequently
form new conjugates with additional specific B cells not yet stimulated.
It is not yet known whether the Th subset(s) that secretes BSF-1 also bears
receptors for it, or whether different subsets secrete and bind the ligand or both.
In this regard, Mosmann et al . (39) have recently shown the existence of two
different types of murine Th clones based on their patterns of lymphokine
secretion. Type 1 Th cells produce IL-2, IFN-,y, GM-CSF, and IL-3, whereas
Type 2 Th cells produce BSF-1, a mast cell growth factor distinct from IL-3,
and a T cell growth factor distinct from IL-2. The effect of BSF-1 on the
proliferation of such clones was not investigated . Nevertheless, the presence of
a T cell growth factor activity, different from IL-2 in the SNs of those clones
also producing BSF-1 (assayed by proliferation of HT-2 cells), suggests that this
T cell growth factor activity might be due to BSF-1.590
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Arthur and Mason (42) have also recently reported that inducer/helper T cells
in the rat can be separated into two functional subsets based on reactivity with
an mAb (MRC OX-22) that recognizes high molecular weight forms of the rat
leukocyte-common antigen. One subset (OX-22+) proliferates well in mixed
lymphocyte culture (MLC), responds to Con A, and produces high levels of IL-
2 after stimulation; this subset would be expected to play a role in cell-mediated
immunity. The other subset (OX-22-) that proliferates poorly in response to
MLC and Con A, produces low levels of IL-2 but provides effective help for B
cell responses; this subset presumably plays an important role in the induction of
humoral responses. Based on these data, the rat CD4+, OX-22- subset would be
expected to produce (and also respond to) a lymphokine analogous to murine
BSF-1 . The effects of BSF-1 on B cell activation and differentiation coupled to
its preferential growth-promoting activity on Th cells could provide the means,
as suggested by Arthur and Mason (42), foran independent regulation of cellular
and humoral immune responses.
During the past year, the complexity of the biologic activities of BSF-1 has
become evident (2-7). Until now, the activity of BSF-1 had been exclusively
associated with B cells. This report provides evidence that BSF-I also acts on
some T cell subpopulations.
Summary
T cell-derived supernatants (SN) that contain B cell-stimulatory factor
1 (BSF-1) and lack IL-2 promote the growth of the IL-2-dependent T cell line,
HT-2, as well as three other clones or lines of T cells that can provide help to B
cells. The BSF-I purified from these SNs promotes growth of HT-2 cells -50%
as effectively as purified IL-2. A potential involvement for contaminating IL-2
in the BSF-I preparations was excluded by the demonstration that anti-BSF-I
mAbs blocked the BSF-1-induced growth of HT-2 cells; in contrast, these
antibodies did not block the IL-2-induced proliferation of the HT-2 cells. In
addition, anti-IL-2 mAbs or anti-IL-2-R antibodies blocked the HT-2 growth-
promoting activity of purified IL-2, but not BSF-1. Finally, BSF-1 promoted only
a very modest growth of Con A-induced T cell blasts, and failed to induce
significant growth in seven other cytotoxic, alloreactive, and long-term T cell
lines. Taken together, these results indicate that in addition to its known effects
on resting and LPS-stimulated B cells, BSF-1 can promote growth of certain
subsets of activated T cells, in particular, those that provide help to B cells.
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Note added in proof Lee et al. (43) have recently generatedamurine cDNA clone for BSF-1. Monkey
COS cells transfected with this cDNA produce BSF-I . This BSF-1 has la-inducing activity, anti-Ig
costimulatory activity, BCDF-y/BCDF-e activity, mast cell stimulatory activity, and HT-2 growth
promotingactivity. Our results are in agreement with thoseof Lee et al .FERNANDEZ-BOTRAN ET AL.
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